Verastem, Inc. Announces Presentations at the 2013 American Association for Cancer Research-NCI-EORTC International Conference
Published: Oct 10, 2013
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced scheduled poster presentations at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics which is taking place October 19-23, 2013 in Boston.
Help employers find you! Check out all the jobs and post your resume.